KHẨU PHẦN 24 GIỜ CỦA NGƯỜI BỆNH UNG THƯ DẠ DÀY ĐIỀU TRỊ HOÁ CHẤT PHÁC ĐỒ XELOX TẠI BỆNH VIỆN K NĂM 2020-2021: NGHIÊN CỨU THEO DÕI DỌC

Abstract

Aims: To assess the 24-hour dietary intake of gastric cancer patients receiving adjuvant XELOX chemotherapy following radical gastrectomy at K Hospital in 2020–2021.

Methods: A follow-up study was conducted on 76 gastric cancer patients receiving adjuvant chemotherapy of the XELOX regimen at the  K hospital. Each patient's 24-hour diet was collected and compared with the 2017 ESPEN recommendations on nutrition for cancer patients at 3 time points: before chemotherapy treatment for the 1st, 4th and 8th cycles according to the regimen.

Results: Prior to chemotherapy, none of the patients met the recommended energy and protein requirements. Total energy, protein, carbohydrate, and lipid intake increased gradually at the time points preceding the 4th and 8th chemotherapy cycles. At each assessment, total energy intake was not statistically significantly lower in patients who underwent total or near-total gastrectomy compared with those who underwent partial gastrectomy (p > 0.05).

Conclusion: The gastric cancer patients receiving adjuvant chemotherapy after surgery demonstrated a high rate of inadequate energy and protein intake. Targeted nutritional interventions are warranted to optimize nutritional status prior to the initiation of chemotherapy.